Related Experiment Videos
Serum IgE levels in paraproteinaemia
International Archives of Allergy and Applied Immunology
|January 1, 1975
Summary
This study found low serum immunoglobulin E (IgE) levels in patients with multiple myeloma or macroglobulinaemia. These findings align with observations for other immunoglobulin classes in these conditions.
Area of Science:
- Immunology
- Hematology
- Oncology
Background:
- Multiple myeloma and macroglobulinaemia are plasma cell disorders characterized by abnormal immunoglobulin production.
- Immunoglobulin E (IgE) plays a role in allergic reactions and parasitic infections.
- Previous research indicates altered levels of other immunoglobulin classes in these hematological malignancies.
Purpose of the Study:
- To investigate serum IgE levels in patients diagnosed with multiple myeloma or macroglobulinaemia.
- To determine if IgE levels follow similar patterns to other immunoglobulins in these conditions.
Main Methods:
- Serum samples were collected from 45 patients with multiple myeloma or macroglobulinaemia.
- Serum IgE concentrations were quantified using radioimmunoassay.
- A commercial assay kit ('Phadesbas test kit') was employed for IgE measurement.
Main Results:
- Significantly low serum IgE levels were detected in the patient cohort.
- The observed low IgE levels were consistent across patients with multiple myeloma and macroglobulinaemia.
- This pattern mirrors the reduced levels of other immunoglobulin classes previously reported in these diseases.
Conclusions:
- Serum IgE levels are diminished in individuals with multiple myeloma and macroglobulinaemia.
- The findings suggest a broader dysregulation of immunoglobulin synthesis in these plasma cell neoplasms.
- Further research may elucidate the mechanisms behind IgE suppression in these hematological conditions.